We considered as local advanced @entity5 (LARC) @entity5 invading the serosa or adherent to neighbouring organs, tumoral @entity292 , histopathologically proved invasion of regional lymph nodes, peritoneal @entity189 with or without @entity5 ascites. Out of 146 @entity5 submitted to surgery between 1984-1996, 47 had LARC (19 @entity1 and 28 @entity1 aged of 19 to 88 years) developed in the inferior 2/3 of rectum. We performed in these cases 11 Miles operations, 12 posterior pelvectomies, 3 Dixon resections, 16 colostomies and 5 exploratory laparotomies. To these were associated 4 partial cystectomies, 4 anexectomies, 4 partial enterectomies and 2 excisions of hepatic @entity3 . In 27 @entity1 adjuvant or neoadjuvant therapy was associated. We registered 3 deaths, 6 parietal infections and 1 stercoral @entity292 . Postoperative survival was 3-6 months for 12 @entity1 , 6-12 months for 13 @entity1 , 1-2 years for 6 @entity1 . After the complex treatment 6 @entity1 were alive at 5 years. Surgery is the essential therapeutic act of LARC. Chemo/radiotherapy association increases the survival, but not significantly.

[The place of surgery in the treatment of locally advanced XXXX ].

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'man'] @entity5 :: ('MESH:D009369', 'Disease') :: ['neoplastic', 'rectal cancers', 'tumours', 'rectal cancer'] @entity189 :: ('MESH:D002277', 'Disease') :: ['carcinomatosis'] @entity292 :: ('MESH:D005402', 'Disease') :: ['fistula', 'fistulas'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis']
@entity5 :: (MESH:D009369,Disease) :: ['rectal cancer']
